{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:42:08Z","timestamp":1787586128341,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.dld.2025.06.017","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:10:33Z","timestamp":1752624633000},"page":"1802-1809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of high-risk hepatoblastoma in the CHIC risk stratification system based on enhanced CT radiomics features"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2299-2337","authenticated-orcid":false,"given":"Yanlin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6700-962X","authenticated-orcid":false,"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6640-5287","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2025.06.017_bib0001","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Spector","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.dld.2025.06.017_bib0002","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.semdp.2016.12.015","article-title":"Hepatoblastoma","volume":"34","author":"Sharma","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.dld.2025.06.017_bib0003","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40880-019-0411-7","article-title":"Incidence trends and survival prediction of hepatoblastoma in children: a population-based study","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun"},{"key":"10.1016\/j.dld.2025.06.017_bib0004","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2025.06.017_bib0005","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.ejca.2012.06.023","article-title":"Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma\u2013a phase II trial of the childhood liver tumour strategy group(SIOPEL)","volume":"48","author":"Zsiros","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2025.06.017_bib0006","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jpedsurg.2017.08.031","article-title":"The role of pulmonary metastasectomy for hepatoblastoma in children with metastasis atdiagnosis: results from the JPLT-2 study","volume":"52","author":"Hishiki","year":"2017","journal-title":"J Pediatr Surg"},{"issue":"5","key":"10.1016\/j.dld.2025.06.017_bib0007","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(18)30895-7","article-title":"Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children\u2019s Oncology Group, multicentre,phase 3 trial","volume":"20","author":"Katzenstein","year":"2019","journal-title":"Lancet Oncol"},{"issue":"17","key":"10.1016\/j.dld.2025.06.017_bib0008","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cis-platin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.dld.2025.06.017_bib0009","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","article-title":"Dose-dense cisplatin-based chemotherapy and surgery for childrenwith high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study","volume":"14","author":"Zsiros","year":"2013","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.dld.2025.06.017_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30302","article-title":"Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach","volume":"70","author":"Srinivasan","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.dld.2025.06.017_bib0011","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12098-017-2301-9","article-title":"Management of hepatoblastoma: ICMR consensus document","volume":"84","author":"Agarwala","year":"2017","journal-title":"Indian J Pediatr"},{"issue":"4","key":"10.1016\/j.dld.2025.06.017_bib0012","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13312-012-0037-1","article-title":"Outcomes of hepatoblastoma in the Indian context","volume":"49","author":"Arora","year":"2012","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.dld.2025.06.017_bib0013","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-\u00adstratified staging inpaediatric hepatoblastoma: a unified analysis from the Children's hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2025.06.017_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.552079","article-title":"CHIC risk stratification system for predicting the survival of children with hepatoblastoma: data from children with hepatoblastoma in China","volume":"10","author":"Huang","year":"2020","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.dld.2025.06.017_bib0015","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1007\/s00330-021-08047-w","article-title":"Outcome of staging chest CT and identification of factors associated with lung metastasis in children with hepatoblastoma","volume":"31","author":"Kim","year":"2021","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.dld.2025.06.017_bib0016","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-018-2821-2","article-title":"Neuroblastoma: clinical and biological approach to risk stratification and treatment","volume":"372","author":"Tolbert","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"2","key":"10.1016\/j.dld.2025.06.017_bib0017","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230255","article-title":"Dual-energy CT deep learning radiomics to predict macrotrabecular-massive hepatocellular carcinoma","volume":"308","author":"Li","year":"2023","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.dld.2025.06.017_bib0018","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00261-021-03190-w","article-title":"Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review","volume":"47","author":"Perik","year":"2022","journal-title":"Abdom Radiol"},{"issue":"8","key":"10.1016\/j.dld.2025.06.017_bib0019","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.clon.2024.03.003","article-title":"Radiomics for clinical decision support in radiation oncology","volume":"36","author":"Russo","year":"2024","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.dld.2025.06.017_bib0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00432-024-05746-x","article-title":"Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics","volume":"150","author":"Yang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"10.1016\/j.dld.2025.06.017_bib0021","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/cncr.30591","article-title":"Upfront window vincristine\/irinotecan treatment of high-risk hepatoblastoma: a report from the Children's Oncology Group AHEP0731 study committee","volume":"123","author":"Katzenstein","year":"2017","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.dld.2025.06.017_bib0022","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1007\/s00330-021-07998-4","article-title":"Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation","volume":"31","author":"Markich","year":"2021","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.dld.2025.06.017_bib0023","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/ajt.16945","article-title":"Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: experience from the Society of Pediatric Liver Transplantation (SPLIT)","volume":"22","author":"Boster","year":"2022","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.dld.2025.06.017_bib0024","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrclinonc.2016.162","article-title":"Imaging biomarker roadmap for cancer studies","volume":"14","author":"O'Connor","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.dld.2025.06.017_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1093526619875228","article-title":"Hepatoblastoma and pediatric hepatocellular carcinoma: an update","volume":"23","author":"Ranganathan","year":"2020","journal-title":"Pediatr Dev Pathol"},{"issue":"2","key":"10.1016\/j.dld.2025.06.017_bib0026","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232303","article-title":"Accuracy of an artificial intelligence system for interval breast cancer detection at screening mammography","volume":"312","author":"Nanaa","year":"2024","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.dld.2025.06.017_bib0027","article-title":"Association of computed tomography radiomics signature with progression-free survival in neuroblastoma patients","volume":"35","year":"2023","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.dld.2025.06.017_bib0028","article-title":"Identification of an ultra-high-risk subgroup of neuroblastoma patients within the high-risk cohort using a computed tomography-based radiomics approach","volume":"31","year":"2023","journal-title":"Acad Radiol"},{"key":"10.1016\/j.dld.2025.06.017_bib0029","doi-asserted-by":"crossref","DOI":"10.1007\/s00247-023-05793-5","article-title":"Computed tomography imaging phenotypes of hepatoblastoma identified from radiomics signatures are associated with the efficacy of neoadjuvant chemotherapy","author":"Chen","year":"2023","journal-title":"Pediatr Radiol"},{"issue":"2","key":"10.1016\/j.dld.2025.06.017_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1078-0432.CCR-14-0990","article-title":"Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome","volume":"21","author":"O'Connor","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.dld.2025.06.017_bib0031","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01470-5","article-title":"A wavelet features derived radiomics nomogram for prediction of malignant and benign early-stage lung nodules","volume":"11","author":"Jing","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2025.06.017_bib0032","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.dld.2025.06.017_bib0033","doi-asserted-by":"crossref","first-page":"548e553","DOI":"10.1016\/j.radonc.2018.07.027","article-title":"Texture analysis of 3D dose distributions forpredictive modelling of toxicity rates in radiotherapy","volume":"129","author":"Rossi","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.dld.2025.06.017_bib0034","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1038\/s41467-023-39717-6","article-title":"Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma","volume":"14","author":"Fang","year":"2023","journal-title":"Nat Commun"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825008825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825008825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T08:35:43Z","timestamp":1756110943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865825008825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1590865825008825"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.06.017","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of high-risk hepatoblastoma in the CHIC risk stratification system based on enhanced CT radiomics features","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}